Cost-effectiveness analysis of OM-85 vs placebo in the prevention of acute respiratory tract infections (ARTIs) in children that attend day-care centers
Abstract Background Children that attend day-care centers frequently contract acute respiratory tract infections (ARTIs). ARTIs represent a burden for both children and parents. Systematic reviews on the use of immunostimulants for the prevention of juvenile recurrent ARTIs have provided moderate ev...
Main Authors: | Arturo Berber, Blanca Estela Del-Rio-Navarro |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Health Economics Review |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13561-019-0230-1 |
Similar Items
-
Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85
by: U. B. Schaad
Published: (2005-12-01) -
Costo/efficacia della prevenzione di infezioni alle prime vie aeree mediante un estratto batterico immunostimolante aspecifico (OM-85)
by: Orietta Zaniolo, et al.
Published: (2005-09-01) -
A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections
by: Susanna Esposito, et al.
Published: (2019-08-01) -
Can bacterial lysates be useful in prevention of viral respiratory infections in childhood? The results of experimental OM-85 studies
by: Stefania Ballarini, et al.
Published: (2022-11-01) -
Microbiota profiles in pre-school children with respiratory infections: Modifications induced by the oral bacterial lysate OM-85
by: Susanna Esposito, et al.
Published: (2022-08-01)